Related Experiment Video
Updated: Jul 3, 2026
08:49
Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
Published on: August 2, 2024
Natriuretic peptides for guiding heart failure therapy
Shafiq U Rehman1, James L Januzzi
1Massachusetts General Hospital, Boston, MA 02114, USA.
Comprehensive Therapy
|August 7, 2008
Summary
Natriuretic peptides offer accurate diagnosis and prognosis for heart failure. However, their full potential in guiding and adjusting heart failure treatments is still under development.
Area of Science:
- Cardiology
- Biomarkers
- Heart Failure Management
Background:
- Natriuretic peptides are established biomarkers in heart failure.
- These peptides provide valuable diagnostic and prognostic information.
- Current clinical application for therapy guidance is limited.
Purpose of the Study:
- To evaluate the role of natriuretic peptides in guiding heart failure therapy.
- To assess the potential of natriuretic peptides for treatment titration.
Main Methods:
- Review of existing literature on natriuretic peptide use in heart failure.
- Analysis of studies investigating natriuretic peptide-guided therapy.
Main Results:
- Natriuretic peptides demonstrate high accuracy for diagnosis.
- They offer independent prognostic value in heart failure patients.
- Evidence for their routine use in therapy titration remains incomplete.
Conclusions:
- Natriuretic peptide measurement is a valuable tool in heart failure management.
- Further research is needed to fully integrate natriuretic peptides into therapeutic decision-making for heart failure.
More Related Videos
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...